Gastrointestinal Therapeutics Market Size, Share & Industry Analysis, By Product Type (Small Molecules/Conventional Drugs and Biologics & Biosimilars), By Therapy Type (Acid Suppression Therapies {Proton Pump Inhibitor (PPI) and Others}, Targeted Therapies {Antibodies, JAK Inhibitors, and Others}, Anti-Inflammatory & Immunomodulators, Antibiotics, Antiemetics, Motility Agents & Secretagogues, and Others), By Route of Administration (Oral, Parenteral, and Others), By Age Group (Pediatrics and Adults), By Application, By Distribution Channel, and Regional Forecast, 2025-2032

Last Updated: December 08, 2025 | Format: PDF | Report ID: FBI114337

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Overview: Technological Advancements in Gastrointestinal Therapeutics
2. Regulatory Scenario, By Key Countries/Regions
3. Key Industry Developments (Mergers, Acquisitions, and Collaborations etc.)
4. New Product Launches, By Key Players
Global Gastrointestinal Therapeutics Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product Type Type
  1. Small Molecules/Conventional Drugs
  2. Biologics & Biosimilars
2. Market Analysis, Insights and Forecast – By Therapy Type
  1. Acid Suppression Therapies
    1. Proton Pump Inhibitor (PPI)
    2. Others
  2. Targeted Therapies
    1. Antibodies
    2. JAK Inhibitors
    3. Others
  3. Anti-Inflammatory & Immunomodulators
  4. Antibiotics
  5. Antiemetics
  6. Motility Agents & Secretagogues
  7. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Others
4. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatrics
  2. Adults
5. Market Analysis, Insights and Forecast – By Application
  1. Gastroesophageal Reflux Disease (GERD)
  2. Functional Gastrointestinal Disorders (FGIDs)
  3. Irritable Bowel Syndrome (IBS)
  4. Inflammatory Bowel Disease (IBD)
  5. GI Cancers
  6. Others
6. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
7. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Gastrointestinal Therapeutics Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product Type Type
  1. Small Molecules/Conventional Drugs
  2. Biologics & Biosimilars
2. Market Analysis, Insights and Forecast – By Therapy Type
  1. Acid Suppression Therapies
    1. Proton Pump Inhibitor (PPI)
    2. Others
  2. Targeted Therapies
    1. Antibodies
    2. JAK Inhibitors
    3. Others
  3. Anti-Inflammatory & Immunomodulators
  4. Antibiotics
  5. Antiemetics
  6. Motility Agents & Secretagogues
  7. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Others
4. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatrics
  2. Adults
5. Market Analysis, Insights and Forecast – By Application
  1. Gastroesophageal Reflux Disease (GERD)
  2. Functional Gastrointestinal Disorders (FGIDs)
  3. Irritable Bowel Syndrome (IBS)
  4. Inflammatory Bowel Disease (IBD)
  5. GI Cancers
  6. Others
6. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
7. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Gastrointestinal Therapeutics Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product Type Type
  1. Small Molecules/Conventional Drugs
  2. Biologics & Biosimilars
2. Market Analysis, Insights and Forecast – By Therapy Type
  1. Acid Suppression Therapies
    1. Proton Pump Inhibitor (PPI)
    2. Others
  2. Targeted Therapies
    1. Antibodies
    2. JAK Inhibitors
    3. Others
  3. Anti-Inflammatory & Immunomodulators
  4. Antibiotics
  5. Antiemetics
  6. Motility Agents & Secretagogues
  7. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Others
4. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatrics
  2. Adults
5. Market Analysis, Insights and Forecast – By Application
  1. Gastroesophageal Reflux Disease (GERD)
  2. Functional Gastrointestinal Disorders (FGIDs)
  3. Irritable Bowel Syndrome (IBS)
  4. Inflammatory Bowel Disease (IBD)
  5. GI Cancers
  6. Others
6. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
7. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Gastrointestinal Therapeutics Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product Type Type
  1. Small Molecules/Conventional Drugs
  2. Biologics & Biosimilars
2. Market Analysis, Insights and Forecast – By Therapy Type
  1. Acid Suppression Therapies
    1. Proton Pump Inhibitor (PPI)
    2. Others
  2. Targeted Therapies
    1. Antibodies
    2. JAK Inhibitors
    3. Others
  3. Anti-Inflammatory & Immunomodulators
  4. Antibiotics
  5. Antiemetics
  6. Motility Agents & Secretagogues
  7. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Others
4. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatrics
  2. Adults
5. Market Analysis, Insights and Forecast – By Application
  1. Gastroesophageal Reflux Disease (GERD)
  2. Functional Gastrointestinal Disorders (FGIDs)
  3. Irritable Bowel Syndrome (IBS)
  4. Inflammatory Bowel Disease (IBD)
  5. GI Cancers
  6. Others
6. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
7. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Gastrointestinal Therapeutics Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product Type Type
  1. Small Molecules/Conventional Drugs
  2. Biologics & Biosimilars
2. Market Analysis, Insights and Forecast – By Therapy Type
  1. Acid Suppression Therapies
    1. Proton Pump Inhibitor (PPI)
    2. Others
  2. Targeted Therapies
    1. Antibodies
    2. JAK Inhibitors
    3. Others
  3. Anti-Inflammatory & Immunomodulators
  4. Antibiotics
  5. Antiemetics
  6. Motility Agents & Secretagogues
  7. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Others
4. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatrics
  2. Adults
5. Market Analysis, Insights and Forecast – By Application
  1. Gastroesophageal Reflux Disease (GERD)
  2. Functional Gastrointestinal Disorders (FGIDs)
  3. Irritable Bowel Syndrome (IBS)
  4. Inflammatory Bowel Disease (IBD)
  5. GI Cancers
  6. Others
6. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
7. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Gastrointestinal Therapeutics Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product Type Type
  1. Small Molecules/Conventional Drugs
  2. Biologics & Biosimilars
2. Market Analysis, Insights and Forecast – By Therapy Type
  1. Acid Suppression Therapies
    1. Proton Pump Inhibitor (PPI)
    2. Others
  2. Targeted Therapies
    1. Antibodies
    2. JAK Inhibitors
    3. Others
  3. Anti-Inflammatory & Immunomodulators
  4. Antibiotics
  5. Antiemetics
  6. Motility Agents & Secretagogues
  7. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Others
4. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatrics
  2. Adults
5. Market Analysis, Insights and Forecast – By Application
  1. Gastroesophageal Reflux Disease (GERD)
  2. Functional Gastrointestinal Disorders (FGIDs)
  3. Irritable Bowel Syndrome (IBS)
  4. Inflammatory Bowel Disease (IBD)
  5. GI Cancers
  6. Others
6. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
7. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
  1. Johnson & Johnson
  2. AbbVie Inc.
  3. Takeda Pharmaceutical Company Limited
  4. Bristol-Myers Squibb Company
  5. Bayer AG
  6. Pfizer Inc.
  7. Abbott
  8. UCB S.A.
  9. Bausch Health Companies Inc.
  10. CELLTRION INC.

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Overview: Technological Advancements in Gastrointestinal Therapeutics
2. Regulatory Scenario, By Key Countries/Regions
3. Key Industry Developments (Mergers, Acquisitions, and Collaborations etc.)
4. New Product Launches, By Key Players
Global Gastrointestinal Therapeutics Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product Type Type
  1. Small Molecules/Conventional Drugs
  2. Biologics & Biosimilars
2. Market Analysis, Insights and Forecast – By Therapy Type
  1. Acid Suppression Therapies
    1. Proton Pump Inhibitor (PPI)
    2. Others
  2. Targeted Therapies
    1. Antibodies
    2. JAK Inhibitors
    3. Others
  3. Anti-Inflammatory & Immunomodulators
  4. Antibiotics
  5. Antiemetics
  6. Motility Agents & Secretagogues
  7. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Others
4. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatrics
  2. Adults
5. Market Analysis, Insights and Forecast – By Application
  1. Gastroesophageal Reflux Disease (GERD)
  2. Functional Gastrointestinal Disorders (FGIDs)
  3. Irritable Bowel Syndrome (IBS)
  4. Inflammatory Bowel Disease (IBD)
  5. GI Cancers
  6. Others
6. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
7. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Gastrointestinal Therapeutics Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product Type Type
  1. Small Molecules/Conventional Drugs
  2. Biologics & Biosimilars
2. Market Analysis, Insights and Forecast – By Therapy Type
  1. Acid Suppression Therapies
    1. Proton Pump Inhibitor (PPI)
    2. Others
  2. Targeted Therapies
    1. Antibodies
    2. JAK Inhibitors
    3. Others
  3. Anti-Inflammatory & Immunomodulators
  4. Antibiotics
  5. Antiemetics
  6. Motility Agents & Secretagogues
  7. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Others
4. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatrics
  2. Adults
5. Market Analysis, Insights and Forecast – By Application
  1. Gastroesophageal Reflux Disease (GERD)
  2. Functional Gastrointestinal Disorders (FGIDs)
  3. Irritable Bowel Syndrome (IBS)
  4. Inflammatory Bowel Disease (IBD)
  5. GI Cancers
  6. Others
6. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
7. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Gastrointestinal Therapeutics Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product Type Type
  1. Small Molecules/Conventional Drugs
  2. Biologics & Biosimilars
2. Market Analysis, Insights and Forecast – By Therapy Type
  1. Acid Suppression Therapies
    1. Proton Pump Inhibitor (PPI)
    2. Others
  2. Targeted Therapies
    1. Antibodies
    2. JAK Inhibitors
    3. Others
  3. Anti-Inflammatory & Immunomodulators
  4. Antibiotics
  5. Antiemetics
  6. Motility Agents & Secretagogues
  7. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Others
4. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatrics
  2. Adults
5. Market Analysis, Insights and Forecast – By Application
  1. Gastroesophageal Reflux Disease (GERD)
  2. Functional Gastrointestinal Disorders (FGIDs)
  3. Irritable Bowel Syndrome (IBS)
  4. Inflammatory Bowel Disease (IBD)
  5. GI Cancers
  6. Others
6. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
7. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Gastrointestinal Therapeutics Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product Type Type
  1. Small Molecules/Conventional Drugs
  2. Biologics & Biosimilars
2. Market Analysis, Insights and Forecast – By Therapy Type
  1. Acid Suppression Therapies
    1. Proton Pump Inhibitor (PPI)
    2. Others
  2. Targeted Therapies
    1. Antibodies
    2. JAK Inhibitors
    3. Others
  3. Anti-Inflammatory & Immunomodulators
  4. Antibiotics
  5. Antiemetics
  6. Motility Agents & Secretagogues
  7. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Others
4. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatrics
  2. Adults
5. Market Analysis, Insights and Forecast – By Application
  1. Gastroesophageal Reflux Disease (GERD)
  2. Functional Gastrointestinal Disorders (FGIDs)
  3. Irritable Bowel Syndrome (IBS)
  4. Inflammatory Bowel Disease (IBD)
  5. GI Cancers
  6. Others
6. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
7. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Gastrointestinal Therapeutics Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product Type Type
  1. Small Molecules/Conventional Drugs
  2. Biologics & Biosimilars
2. Market Analysis, Insights and Forecast – By Therapy Type
  1. Acid Suppression Therapies
    1. Proton Pump Inhibitor (PPI)
    2. Others
  2. Targeted Therapies
    1. Antibodies
    2. JAK Inhibitors
    3. Others
  3. Anti-Inflammatory & Immunomodulators
  4. Antibiotics
  5. Antiemetics
  6. Motility Agents & Secretagogues
  7. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Others
4. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatrics
  2. Adults
5. Market Analysis, Insights and Forecast – By Application
  1. Gastroesophageal Reflux Disease (GERD)
  2. Functional Gastrointestinal Disorders (FGIDs)
  3. Irritable Bowel Syndrome (IBS)
  4. Inflammatory Bowel Disease (IBD)
  5. GI Cancers
  6. Others
6. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
7. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Gastrointestinal Therapeutics Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product Type Type
  1. Small Molecules/Conventional Drugs
  2. Biologics & Biosimilars
2. Market Analysis, Insights and Forecast – By Therapy Type
  1. Acid Suppression Therapies
    1. Proton Pump Inhibitor (PPI)
    2. Others
  2. Targeted Therapies
    1. Antibodies
    2. JAK Inhibitors
    3. Others
  3. Anti-Inflammatory & Immunomodulators
  4. Antibiotics
  5. Antiemetics
  6. Motility Agents & Secretagogues
  7. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
  3. Others
4. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatrics
  2. Adults
5. Market Analysis, Insights and Forecast – By Application
  1. Gastroesophageal Reflux Disease (GERD)
  2. Functional Gastrointestinal Disorders (FGIDs)
  3. Irritable Bowel Syndrome (IBS)
  4. Inflammatory Bowel Disease (IBD)
  5. GI Cancers
  6. Others
6. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
7. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
  1. Johnson & Johnson
  2. AbbVie Inc.
  3. Takeda Pharmaceutical Company Limited
  4. Bristol-Myers Squibb Company
  5. Bayer AG
  6. Pfizer Inc.
  7. Abbott
  8. UCB S.A.
  9. Bausch Health Companies Inc.
  10. CELLTRION INC.

Read Less

List of Figures

Figure 1: Global Gastrointestinal Therapeutics Market Revenue Breakdown (USD Billion, %) By Region, 2024 & 2032

Figure 2: Global Gastrointestinal Therapeutics Market Value Share (%), By Product Type, 2024 & 2032

Figure 3: Global Gastrointestinal Therapeutics Market Value Share (%), By Therapy Type, 2024 & 2032

Figure 4: Global Gastrointestinal Therapeutics Market Value Share (%), By Route of Administration, 2024 & 2032

Figure 5: Global Gastrointestinal Therapeutics Market Value Share (%), By Age Group, 2024 & 2032

Figure 6: Global Gastrointestinal Therapeutics Market Value Share (%), By Application, 2024 & 2032

Figure 7: Global Gastrointestinal Therapeutics Market Value Share (%), By Distribution Channel, 2024 & 2032

Figure 8: Global Gastrointestinal Therapeutics Market Value (USD Billion), By Region, 2024 & 2032

Figure 9: North America Gastrointestinal Therapeutics Market Value (USD Billion), By Product Type, 2024 & 2032

Figure 10: North America Gastrointestinal Therapeutics Market Value Share (%), By Product Type, 2024

Figure 11: North America Gastrointestinal Therapeutics Market Value (USD Billion), By Therapy Type, 2024 & 2032

Figure 12: North America Gastrointestinal Therapeutics Market Value Share (%), By Therapy Type, 2024

Figure 13: North America Gastrointestinal Therapeutics Market Value (USD Billion), By Route of Administration, 2024 & 2032

Figure 14: North America Gastrointestinal Therapeutics Market Value Share (%), By Route of Administration, 2024

Figure 15: North America Gastrointestinal Therapeutics Market Value (USD Billion), By Age Group, 2024 & 2032

Figure 16: North America Gastrointestinal Therapeutics Market Value Share (%), By Age Group, 2024

Figure 17: North America Gastrointestinal Therapeutics Market Value (USD Billion), By Application, 2024 & 2032

Figure 18: North America Gastrointestinal Therapeutics Market Value Share (%), By Application, 2024

Figure 19: North America Gastrointestinal Therapeutics Market Value (USD Billion), By Distribution Channel, 2024 & 2032

Figure 20: North America Gastrointestinal Therapeutics Market Value Share (%), By Distribution Channel, 2024

Figure 21: North America Gastrointestinal Therapeutics Market Value (USD Billion), By Country, 2024 & 2032

Figure 22: North America Gastrointestinal Therapeutics Market Value Share (%), By Country, 2024

Figure 23: Europe Gastrointestinal Therapeutics Market Value (USD Billion), By Product Type, 2024 & 2032

Figure 24: Europe Gastrointestinal Therapeutics Market Value Share (%), By Product Type, 2024

Figure 25: Europe Gastrointestinal Therapeutics Market Value (USD Billion), By Therapy Type, 2024 & 2032

Figure 26: Europe Gastrointestinal Therapeutics Market Value Share (%), By Therapy Type, 2024

Figure 27: Europe Gastrointestinal Therapeutics Market Value (USD Billion), By Route of Administration, 2024 & 2032

Figure 28: Europe Gastrointestinal Therapeutics Market Value Share (%), By Route of Administration, 2024

Figure 29: Europe Gastrointestinal Therapeutics Market Value (USD Billion), By Age Group, 2024 & 2032

Figure 30: Europe Gastrointestinal Therapeutics Market Value Share (%), By Age Group, 2024

Figure 31: Europe Gastrointestinal Therapeutics Market Value (USD Billion), By Application, 2024 & 2032

Figure 32: Europe Gastrointestinal Therapeutics Market Value Share (%), By Application, 2024

Figure 33: Europe Gastrointestinal Therapeutics Market Value (USD Billion), By Distribution Channel, 2024 & 2032

Figure 34: Europe Gastrointestinal Therapeutics Market Value Share (%), By Distribution Channel, 2024

Figure 35: Europe Gastrointestinal Therapeutics Market Value (USD Billion), By Country/ Sub-region, 2024 & 2032

Figure 36: Europe Gastrointestinal Therapeutics Market Value Share (%), By Country/ Sub-region, 2024

Figure 37: Asia Pacific Gastrointestinal Therapeutics Market Value (USD Billion), By Product Type, 2024 & 2032

Figure 38: Asia Pacific Gastrointestinal Therapeutics Market Value Share (%), By Product Type, 2024

Figure 39: Asia Pacific Gastrointestinal Therapeutics Market Value (USD Billion), By Therapy Type, 2024 & 2032

Figure 40: Asia Pacific Gastrointestinal Therapeutics Market Value Share (%), By Therapy Type, 2024

Figure 41: Asia Pacific Gastrointestinal Therapeutics Market Value (USD Billion), By Route of Administration, 2024 & 2032

Figure 42: Asia Pacific Gastrointestinal Therapeutics Market Value Share (%), By Route of Administration, 2024

Figure 43: Asia Pacific Gastrointestinal Therapeutics Market Value (USD Billion), By Age Group, 2024 & 2032

Figure 44: Asia Pacific Gastrointestinal Therapeutics Market Value Share (%), By Age Group, 2024

Figure 45: Asia Pacific Gastrointestinal Therapeutics Market Value (USD Billion), By Application, 2024 & 2032

Figure 46: Asia Pacific Gastrointestinal Therapeutics Market Value Share (%), By Application, 2024

Figure 47: Asia Pacific Gastrointestinal Therapeutics Market Value (USD Billion), By Distribution Channel, 2024 & 2032

Figure 48: Asia Pacific Gastrointestinal Therapeutics Market Value Share (%), By Distribution Channel, 2024

Figure 49: Asia Pacific Gastrointestinal Therapeutics Market Value (USD Billion), By Country/ Sub-region, 2024 & 2032

Figure 50: Asia Pacific Gastrointestinal Therapeutics Market Value Share (%), By Country/ Sub-region, 2024

Figure 51: Latin America Gastrointestinal Therapeutics Market Value (USD Billion), By Product Type, 2024 & 2032

Figure 52: Latin America Gastrointestinal Therapeutics Market Value Share (%), By Product Type, 2024

Figure 53: Latin America Gastrointestinal Therapeutics Market Value (USD Billion), By Therapy Type, 2024 & 2032

Figure 54: Latin America Gastrointestinal Therapeutics Market Value Share (%), By Therapy Type, 2024

Figure 55: Latin America Gastrointestinal Therapeutics Market Value (USD Billion), By Route of Administration, 2024 & 2032

Figure 56: Latin America Gastrointestinal Therapeutics Market Value Share (%), By Route of Administration, 2024

Figure 57: Latin America Gastrointestinal Therapeutics Market Value (USD Billion), By Age Group, 2024 & 2032

Figure 58: Latin America Gastrointestinal Therapeutics Market Value Share (%), By Age Group, 2024

Figure 59: Latin America Gastrointestinal Therapeutics Market Value (USD Billion), By Application, 2024 & 2032

Figure 60: Latin America Gastrointestinal Therapeutics Market Value Share (%), By Application, 2024

Figure 61: Latin America Gastrointestinal Therapeutics Market Value (USD Billion), By Distribution Channel, 2024 & 2032

Figure 62: Latin America Gastrointestinal Therapeutics Market Value Share (%), By Distribution Channel, 2024

Figure 63: Latin America Gastrointestinal Therapeutics Market Value (USD Billion), By Country/ Sub-region, 2024 & 2032

Figure 64: Latin America Gastrointestinal Therapeutics Market Value Share (%), By Country/ Sub-region, 2024

Figure 65: Middle East & Africa Gastrointestinal Therapeutics Market Value (USD Billion), By Product Type, 2024 & 2032

Figure 66: Middle East & Africa Gastrointestinal Therapeutics Market Value Share (%), By Product Type, 2024

Figure 67: Middle East & Africa Gastrointestinal Therapeutics Market Value (USD Billion), By Therapy Type, 2024 & 2032

Figure 68: Middle East & Africa Gastrointestinal Therapeutics Market Value Share (%), By Therapy Type, 2024

Figure 69: Middle East & Africa Gastrointestinal Therapeutics Market Value (USD Billion), By Route of Administration, 2024 & 2032

Figure 70: Middle East & Africa Gastrointestinal Therapeutics Market Value Share (%), By Route of Administration, 2024

Figure 71: Middle East & Africa Gastrointestinal Therapeutics Market Value (USD Billion), By Age Group, 2024 & 2032

Figure 72: Middle East & Africa Gastrointestinal Therapeutics Market Value Share (%), By Age Group, 2024

Figure 73: Middle East & Africa Gastrointestinal Therapeutics Market Value (USD Billion), By Application, 2024 & 2032

Figure 74: Middle East & Africa Gastrointestinal Therapeutics Market Value Share (%), By Application, 2024

Figure 75: Middle East & Africa Gastrointestinal Therapeutics Market Value (USD Billion), By Distribution Channel, 2024 & 2032

Figure 76: Middle East & Africa Gastrointestinal Therapeutics Market Value Share (%), By Distribution Channel, 2024

Figure 77: Middle East & Africa Gastrointestinal Therapeutics Market Value (USD Billion), By Country/ Sub-region, 2024 & 2032

Figure 78: Middle East & Africa Gastrointestinal Therapeutics Market Value Share (%), By Country/ Sub-region, 2024

Figure 79: Global Gastrointestinal Therapeutics Market Share (%), By Company, 2024

List of Tables

Table 1: Global Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Product Type, 2019–2032

Table 2: Global Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Therapy Type, 2019–2032

Table 3: Global Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Acid Suppression Therapies, 2019–2032

Table 4: Global Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Targeted Therapies, 2019–2032

Table 5: Global Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Route of Administration, 2019–2032

Table 6: Global Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Age Group, 2019–2032

Table 7: Global Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Application, 2019–2032

Table 8: Global Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Distribution Channel, 2019–2032

Table 9: Global Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Region, 2019-2032

Table 10: North America Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Product Type, 2019-2032

Table 11: North America Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Acid Suppression Therapies, 2019–2032

Table 12: North America Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Targeted Therapies, 2019–2032

Table 13: North America Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Therapy Type, 2019-2032

Table 14: North America Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Route of Administration, 2019-2032

Table 15: North America Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Age Group, 2019-2032

Table 16: North America Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Application, 2019-2032

Table 17: North America Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Distribution Channel, 2019-2032

Table 18: North America Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Country, 2019-2032

Table 19: Europe Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Product Type, 2019-2032

Table 20: Europe Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Acid Suppression Therapies, 2019–2032

Table 21: Europe Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Targeted Therapies, 2019–2032

Table 22: Europe Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Therapy Type, 2019-2032

Table 23: Europe Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Route of Administration, 2019-2032

Table 24: Europe Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Age Group, 2019-2032

Table 25: Europe Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Application, 2019-2032

Table 26: Europe Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Distribution Channel, 2019-2032

Table 27: Europe Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2019-2032

Table 28: Asia Pacific Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Product Type, 2019-2032

Table 29: Asia Pacific Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Acid Suppression Therapies, 2019–2032

Table 30: Asia Pacific Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Targeted Therapies, 2019–2032

Table 31: Asia Pacific Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Therapy Type, 2019-2032

Table 32: Asia Pacific Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Route of Administration, 2019-2032

Table 33: Asia Pacific Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Age Group, 2019-2032

Table 34: Asia Pacific Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Application, 2019-2032

Table 35: Asia Pacific Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Distribution Channel, 2019-2032

Table 36: Asia Pacific Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2019-2032

Table 37: Latin America Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Product Type, 2019-2032

Table 38: Latin America Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Acid Suppression Therapies, 2019–2032

Table 39: Latin America Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Targeted Therapies, 2019–2032

Table 40: Latin America Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Therapy Type, 2019-2032

Table 41: Latin America Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Route of Administration, 2019-2032

Table 42: Latin America Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Age Group, 2019-2032

Table 43: Latin America Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Application, 2019-2032

Table 44: Latin America Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Distribution Channel, 2019-2032

Table 45: Latin America Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2019-2032

Table 46: Middle East & Africa Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Product Type, 2019-2032

Table 47: Middle East & Africa Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Acid Suppression Therapies, 2019–2032

Table 48: Middle East & Africa Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Targeted Therapies, 2019–2032

Table 49: Middle East & Africa Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Therapy Type, 2019-2032

Table 50: Middle East & Africa Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Route of Administration, 2019-2032

Table 51: Middle East & Africa Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Age Group, 2019-2032

Table 52: Middle East & Africa Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Application, 2019-2032

Table 53: Middle East & Africa Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Distribution Channel, 2019-2032

Table 54: Middle East & Africa Gastrointestinal Therapeutics Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2019-2032

STUDY PERIOD: 2019-2032
BASE YEAR: 2024
HISTORICAL DATA: 2019-2023
NO OF PAGES: 225

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com